NASDAQ:FOLD

Amicus Therapeutics Stock Predictions

etoro logo Buy FOLD
*Your capital is at risk
$14.49
+0 (+0%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

FOLD Prediction Chart

FOLD Predictions History

Latest community submissions for FOLD.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 30, 2025 Bullish $5.73 X 0
Sep 28, 2023 $12.70 -1.37% $11.86 V 92.89% 1
Sep 28, 2023 $12.77 -0.86% $11.86 V 92.33% 1
JS JS Pro
Sep 28, 2023 $12.78 -0.78% $11.86 V 92.24% 1
Sep 27, 2023 $12.41 +1.38% $12.88 V 96.34% 1
Sep 27, 2023 $12.35 +0.86% $12.88 V 95.85% 1
JS JS Pro
Sep 27, 2023 $12.43 +1.55% $12.88 V 96.51% 1
JS JS Pro
Jan 24, 2023 $13.08 +0.15% $13.39 V 97.68% 1
Jan 24, 2023 $12.85 -1.60% $13.39 X 95.97% 0
Jan 24, 2023 $12.93 -1.00% $13.39 X 96.56% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for FOLD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AMICUS THERAPEUTICS
Amicus Therapeutics
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE